ABF Pharmaceutical Services GmbH has been classified as "critical infrastructure" by the Federal Chancellery of Austria. This is based on the EU Directive 2008/114/EC, which defines the criteria according to which such infrastructure is identified and designated - namely, when a facility or part of a facility is "essential for maintaining important societal functions, health, safety, security and the economic or social well-being of the population and the disruption or destruction of which would have a significant impact because its functions could not be maintained". On the basis of this guideline, the Federal Chancellery and the Ministry of the Interior have drawn up a master plan for 2014 to ensure security of supply in key areas of society. The importance of ABF for the possibility of conducting clinical studies has now led to such a classification.

Press Release

• New diagnostic capability for both virus and antibody detection
• COVID-19 testing is becoming the standard in clinical trials outside of COVID-19 research

• LKF is a global medical laboratory providing all analyses for clinical development

• State government declares LKF to be of systemic importance and essential for the protection of the population

ABF Pharmaceutical Services GmbH has been classified as "critical infrastructure" by the Federal Chancellery of Austria. This is based on the EU Directive 2008/114/EC, which defines the criteria according to which such infrastructure is identified and designated - namely, when a facility or part of a facility is "essential for maintaining important societal functions, health, safety, security and the economic or social well-being of the population and the disruption or destruction of which would have a significant impact because its functions could not be maintained". On the basis of this guideline, the Federal Chancellery and the Ministry of the Interior have drawn up a master plan for 2014 to ensure security of supply in key areas of society. The importance of ABF for the possibility of conducting clinical studies has now led to such a classification.

Elisabeth Lackner now knows her way around the conference facilities at the legendary Westin St. Francis luxury hotel, centrally located on San Francisco's Union Square, with a glass elevator overlooking the city. For years she has been attending the most important pharmaceutical conference there, which the US investment conference JP Morgan always organizes at the beginning of January. In the corridors, she welcomes industry colleagues from all over the world and follows with great interest the fact that this year again several CEOs took the time to talk about the most important pharmaceutical trends in the US election year. "We have become so important that we have to be present at this important industry event," explains the petite pharmaceutical entrepreneur confidently.

Press Release

Security of supply during the coronavirus crisis: ABF Pharmaceutical Services classified as "critical infrastructure" by the Federal Chancellery

"The classification of our company as a ‘critical infrastructure’ is very important for our business partners in the pharmaceutical and biotech industry as well as for patients and doctors, especially during the current coronavirus crisis. This is because the classification ensures that our operations can continue even in the event of a complete shutdown of the economy and that we thus would be able to continue to fulfill our mandate to supply drugs critical to human health," said Dr Elisabeth Lackner, Chief Executive Officer of ABF Pharmaceutical Services and GBA Group Pharma.